Literature DB >> 3815040

Popliteal artery trauma: a high risk injury.

J E Krige, R A Spence.   

Abstract

The clinical presentation and management of 28 popliteal artery injuries following penetrating and blunt trauma during a 6 year period is reviewed. Clinical and Doppler evaluation identified an arterial injury in 24 (85 per cent) patients. In eight (29 per cent) patients with arteriovenous fistulae or false aneurysms, pedal pulses were palpable during initial assessment. Three (10.7 per cent) patients had limb amputation attributable to delayed vascular repair, crush injury and sepsis. End-to-end arterial repair following blunt trauma resulted in early failure with thrombosis in two patients. Autogenous vein grafting was used in 12 patients and is advocated in all blunt popliteal arterial injuries. Routine repair of associated venous injuries and liberal criteria for early fasciotomy were used. Exoskeletal fixation or skeletal traction for compound and comminuted fractures is recommended for simplicity of application and wound management. The significant functional orthopaedic disability following blunt arterial trauma at the knee is emphasized.

Entities:  

Mesh:

Year:  1987        PMID: 3815040     DOI: 10.1002/bjs.1800740206

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  Popliteal artery entrapment syndrome: diagnosis and management, with report of three cases.

Authors:  V Radonić; S Koplić; L Giunio; I Bozić; J Masković; A Buća
Journal:  Tex Heart Inst J       Date:  2000

2.  Lower extremity compartment syndrome in the acute care surgery paradigm: safety lessons learned.

Authors:  Jeffry L Kashuk; Ernest E Moore; Sarah Pinski; Jeffrey L Johnson; John B Moore; Steven Morgan; Clay C Cothren; Wade Smith
Journal:  Patient Saf Surg       Date:  2009-06-15

3.  Bilateral popliteal artery injury: Lessons learned.

Authors:  Tashinga Musonza; Ahmed Khouqueer; Ramyar Gilani
Journal:  Trauma Case Rep       Date:  2019-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.